Maria Carmen Siciliano

Suggest Changes
Learn More
BACKGROUND/AIMS Drugs with antivascular endothelial growth factor A (anti-VEGF-A) action are under clinical evaluation with encouraging results in advanced hepatocellular carcinoma (HCC). The(More)